European Biotechnology Magazine will be back with breaking news and backgrounds on 7 January.
Best wishes
Up To Date
Latest News
Cells that line the blood vessels do not behave identically but instead exhibit varied responses to the same...
Differences in microbiome composition can help to distinguish inflammatory bowel disease (IBD) and irritable...
Cancer specialist Cellestia Biotech AG has secured CHF20m through a Series A financing led by FC Capital, and ...
Staten Biotechnology has signed a dyslipidaemia licence option deal worth US$430m with Novo Nordisk.
Paris-based Kurma Partners announced the first closing of its Kurma Biofund III, a life science fund set to...
Share
